SLC20A2 and Parkinson disease: As the cooccurrence of SLC20A2-associated PFBC with dopamine-responsive parkinsonism is very unusual (3, 8–11), monitoring the dopamine responsiveness of the patient to assess the possible benefits of dopamine replacement therapy is essential.